By
Drug Target Review2025-01-16T08:00:30
UVA Center for Diabetes Technology and Tandem Diabetes Care partner to advance automated insulin delivery systems for diabetes management.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-07-10T06:15:00Z
Contributor Professor Donald E Ingber, By Drug Target Review
2023-01-05T14:41:33
Sponsored by Cell Signaling Technology
2025-06-11T14:00:00
Sponsored by Eurofins Discovery
2025-05-08T09:00:00
Contributor Ning Ren
2025-05-14T14:30:00
Sponsored by Abzena
2025-06-02T10:00:00
Contributor Professor Stefan Trapp, By Drug Target Review
2024-02-06T08:57:06
Sponsored by bit.bio
Site powered by Webvision Cloud